Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 10, 2026

Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid
03:47

Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid

Published on: September 27, 2024

Preventing GLP-1-Associated Facial Aging: An Anatomy-Driven Risk Stratification Model and Prevention Algorithm in the

Ricardo Castrellon1, Karla Maita2, Emily Witt3

  • 1Department of Plastic & Reconstructive Surgery, Larkin Community Hospital, Palm Spring Campus, 1475 W 49th Pl, Hialeah, FL, 33012, USA. researchrcastrellon@gmail.com.

Aesthetic Plastic Surgery
|June 8, 2026
PubMed
Summary

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Billing Opinion Reliability Score 100: A Structured Framework for Billing and Medicolegal Expert Reliability.

Cureus·2026
Same author

Augmentation, Mastopexy, and Augmentation-Mastopexy: Navigating Surgical Decision-Making and Optimizing Outcomes.

Annals of plastic surgery·2026
Same author

Benchmark-Outcome Separation in Federal Independent Dispute Resolution: A Descriptive Analysis of Qualifying Payment Amount and Adjudicated Payment in Complex Repair Claims.

Cureus·2026
Same author

Leonard T. Furlow-Reflections From the Archive-Innovation at the Intersection of Surgery and Imagination.

Annals of plastic surgery·2026
Same author

Anatomic feasibility of intercostal-to-femoral and ulnar-to-sciatic nerve transfers for lower extremity neurotization after traumatic spinal cord injury.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2026
Same author

Small Joint Denervation: Cutting the Cord Without Burning the Bridge.

Annals of plastic surgery·2026

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can cause facial aging. This study proposes a new framework for early identification and prevention of these changes, shifting focus from correction to proactive management.

Area of Science:

  • Medical Science
  • Aesthetics
  • Pharmacology

Background:

  • Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are revolutionizing metabolic care.
  • A notable side effect is rapid, localized facial volume loss, termed 'Ozempic face.'
  • Existing research primarily describes late-stage interventions for this condition.

Purpose of the Study:

  • To introduce an anatomy-driven conceptual framework.
  • To enable early identification and prevention of GLP-1 RA-associated facial aging.
  • To shift clinical focus from reactive correction to proactive management.

Main Methods:

  • A hypothesis-generating model integrating facial aging biomechanics.
  • Analysis of emerging literature on GLP-1 RA effects.
Keywords:
Aesthetic medicineFacial agingGLP-1 receptor agonistsPrevention algorithmRisk stratification

Related Experiment Videos

Last Updated: Jun 10, 2026

Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid
03:47

Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid

Published on: September 27, 2024

  • Incorporation of clinical pattern recognition and risk stratification.

    • Main Results:

    • A risk-stratification model based on anatomical phenotype.
    • A four-phase prevention algorithm linked to weight-loss.
    • Inclusion of early intervention strategies and patient-specific factors.

    Conclusions:

    • The proposed model advocates for preventive, anatomy-based management of GLP-1 RA-induced facial changes.
    • This represents a paradigm shift from reactive treatment to proactive care.
    • Further research is essential to validate and refine this framework.